Hangzhou Tigermed Consulting (03347): As of June 12, a total of 9.0588 million A-shares have been repurchased.

Hangzhou Tigermed Consulting (03347) announced that as of June 12, 2026, the company had repurchased a total of 9.0588 million shares through its special securities account for share repurchases via centralized competitive trading. This represents 1.0521% of the company's current total share capital and 1.2276% of the company's current A-share total share capital. The highest transaction price was 39.96 yuan per share, the lowest transaction price was 38.22 yuan per share, and the total transaction amount was 357 million yuan (excluding transaction fees). This repurchase complies with the company's share repurchase plan and relevant laws and regulations.